How hormones and mastectomy affect chest-related feelings in trans men and gender-diverse people

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study follows AFAB individuals who identify as trans men or gender-diverse before they begin gender-affirming hormone therapy (GAHT) or undergo mastectomy, using the iTransQoL and a chest dysphoria questionnaire to measure outcomes. The primary aim is to analyze psychological and physical effects of breast development on chest dysphoria and related quality of life. A secondary aim is to compare how coping strategies such as binding versus taping relate to stress and well-being. Participants must be German-speaking, able to give informed consent, and attend visits at the Medical University of Innsbruck.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* AFAB (Assigned Female At Birth)
* before starting GAHT
* before mastectomy

Exclusion Criteria:

* Ongoing GAHT
* Mastectomy already performed
* Lack of capacity to give consent
* Insufficient knowledge of German

Where it's running

• Medical University Innsbruck
  Innsbruck, Austria Recruiting

Study contacts

• Study coordinator: Katharina Feil
• Email: katharina.feil@i-med.ac.at
• Phone: +4351250423276

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Effects of testosterone on headaches and brain development in transmasculine youth

  This study is testing how testosterone therapy affects headaches and brain development in transmasculine youth aged 12-20 who were assigned female at birth.

  Recruiting University of Colorado, Denver · Aurora, Colorado · NCT06670053

• Cervical and endometrial cancer screening for people having gender-affirming hysterectomy

  This study will see how often transgender and gender-diverse adults get cervical cancer screening and endometrial sampling before a gender-affirming hysterectomy and whether those tests match what the hysterectomy finds.

  Recruiting University of Minnesota · Minneota, Minnesota · NCT07075731

• Examining how tucking affects semen quality in trans women

  This study is testing how tucking affects sperm quality in trans women who want to preserve their fertility before starting hormone therapy.

  Recruiting Medical University Innsbruck · Innsbruck · NCT06530992

• Investigating how sex hormones affect gut microbiome and heart health in transgender individuals

  This study tests how sex hormones affect gut health and heart risks in transgender individuals receiving hormone therapy.

  Recruiting Charite University, Berlin, Germany · Berlin · NCT05334888

• Gender-affirming hormone therapy for transgender individuals in China

  This study is trying to understand how gender-affirming hormone therapy affects the physical and mental health of transgender individuals in China over a year.

  Recruiting Peking University Third Hospital · Beijing, Beijing Municipality · NCT05318755

• Pain sensitivity during gender‑affirming hormone therapy

  This project will see if starting gender‑affirming hormones changes pain and perception thresholds in transgender adults beginning cross‑sex hormone therapy.

  Recruiting Medical University of Vienna · Vienna, State of Vienna · NCT07148921

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.